• Download Final Program ▶
• Thursday, June 20
• Friday, June 21

Date & Time	6/20(Thu) 11:00-11:30	Place	Hanra (3F)
Integrative cancer genomics for precision medicine in lung cancer Sanghyuk Lee (Department of Life Science, Ewha Womans University)

Date & Time	6/20(Thu) 11:30-12:20	Place	Hanra (3F)
NRG Oncology, an international US NCI-supported cancer research group Walter J. Curran (Winship Cancer Institute of Emory University, USA)

Session Title	Clinical oncology for basic scientists
Date & Time	6/20(Thu) 09:00-10:40	Place	Hanra A (3F)
1) Staging and pathologic features of serous borderline tumor of the ovary related to cancer biology Kyu-Rae Kim (University of Ulsan College of Medicine)
2) Oncologic imaging: Evolving images for evolving treatments Kyung Won Kim (University of Ulsan College of Medicine)
3) Armamentarium in medical oncology: Old and new Inkeun Park (Gachon University College of Medicine)
4) Clinical trials: How to add translational components Yoon Ji Choi (Korea University College of Medicine)

Session Title	Recent advances in understanding and treating advanced GI cancer
Date & Time	6/20(Thu) 09:00-10:40	Place	Hanra B (3F)
1) Pressurized intraperitoneal aerosol chemotherapy Sang Hoon Ahn (Seoul National University College of Medicine)
2) Value of extranodal tumor deposit and extramural vascular invasion in colorectal cancer Sun Jin Park (Kyung Hee University College of Medicine)
3) Alternative preoperative treatment in advanced rectal cancer Hye Jin Kim (Kyungpook National University School of Medicine)
4) Update of treatment for peritoneal metastasis in gastric cancer Jong-Han Kim (Korea University College of Medicine)

Session Title	A strategy of the combination of radiotherapy and immune checkpoint blockade
Date & Time	6/20(Thu) 09:00-10:40	Place	Hanra C (3F)
1) Radiation therapy and anti-tumor immunity; immunological mechanisms of abscopal effect SaeGwang Park (Inje University College of Medicine)
2) A strategy of the combination of radiotherapy and immune checkpoint blockade Jinho Kim (Seoul National University College of Medicine)
3) Propagation of abscopal effect from local therapy Kyong Hwa Park (Korea University College of Medicine)

Session Title	Korean Young Investigator Symposium
Date & Time	6/20(Thu) 09:00-10:40
1) Application of proteomics in translational cancer research Jae-Young Kim (Chungnam National University)
2) Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis Han Sang Kim (Yonsei University College of Medicine)
3) Application of robotic surgery for advanced gynecologic cancers Jiheum Paek (Ajou University School of Medicine)
4) The defense mechanisms of polarized epithelial cells to suppress EMT and tumor metastasis HaeYun Jung (Sungkyunkwan University School of Medicine )

Session Title	Conquering stomach cancer, the major cancer killer in Korea and Japan
Date & Time	6/20(Thu) 13:20-15:00	Place	Hanra A (3F)
1) Epigenetic alterations in gastric epithelial and stromal cells as diagnostic and therapeutic targets Toshikazu Ushijima (National Cancer Center Research Institute, Japan)
2) Integrated proteogenomic analysis of gastric cancers Daehee Hwang (Seoul National University School of Biological Sciences)
3) Stem cell origin of gastric cancers and their niche Yoku Hayakawa (The University of Tokyo, Japan)
4) Targeting interaction between fibrotic stroma and cancer cell in gastric cancer Hoon Hur (Ajou University School of Medicine)

Session Title	Tissue agnostic drug development
Date & Time	6/20(Thu) 13:20-15:00	Place	Hanra B (3F)
1) The first biomarker-Defined tumor indication: Pembrolizumab for MSI-high cancer Kenneth Emancipator (MSD, USA)
2) Development of Larotrectinib in NTRK fusion positive tumors Nicoletta Brega (Bayer, Italy)
3) Challenges of tissue agnostic cancer drug approval and utility Myung-Ju Ahn (Sungkyunkwan University School of Medicine)

Session Title	Updates on head and neck-thyroid oncology
Date & Time	6/20(Thu) 13:20-15:00	Place	Hanra C (3F)
1) Common artery resection and vascular reconstruction in the treatment of head and carotid tumors invading common carotid artery Xiaolei Wang (The Cancer Institute and Hospital, Chinese Academy of Medical Sciences, China)
2) Targeting HGF for head and neck cancer treat Chul-Ho Kim (Ajou University School of Medicine)
3) Personalized TPF induction chemotherapy on the basis of stathmin expression in patients with locally advanced oral squamous cell carcinoma Lai-ping Zhong (Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, China)
4) Personalized treatment strategies in anaplastic thyroid cancer by targeting genomic alterations Young Joo Park (Seoul National University College of Medicine)

Session Title	Immunotherapy for rare cancer
Date & Time	6/20(Thu) 13:20-15:00	Place	Shilla A (3F)
1) Unleashing the innate and adoptive immune systems for the treatment of pediatric solid tumors Robbie G. Majzner (Stanford University School of Medicine, USA)
2) Immune checkpoint blockade immunotherapy for advanced solid tumor of childhood Yasushi Fuchimoto (International University of Health and Welfare School of Medicine, Japan )
3) Exploring combination therapy with B cell and monocyte-based cancer vaccines Chang-Yuil Kang (Seoul National University College of Pharmacy)

Session Title	Strategic plans of improving multicenter clinical trials
Date & Time	6/20(Thu) 13:20-15:00	Place	Baekje B (4F)
1) Database platform for KGOG Chel Hun Choi (Sungkyunkwan University School of Medicine)
2) Beyond the specialty: Collaboration of gynecologic and medical oncology Yong Wha Moon (CHA University School of Medicine)
3) Tips and tricks of recruiting study population Won Park (Sungkyunkwan University School of Medicine)
4) How to make a 'good' clinical trial protocol? Sokbom Kang (National Cancer Center)

Session Title	Vascular regulation of cancer progression
Date & Time	6/20(Thu) 13:20-15:00	Place	Baekje C (4F)
1) Mitochondrial UQCRB, a new player in tumor angiogenesis Ho Jeong Kwon (Yonsei University)
2) Endothelial Notch signaling promotes tumor progression and metastasis Andreas Fischer (German Cancer Research Center(DKFZ), Germany)
3) Deciphering the origin of somatic mutations in brain tumors Jeong Ho Lee (Korea Advanced Institute of Science and Technology)
4) Vascular abnormalities in mouse brain tumor models Injune Kim (Korea Advanced Institute of Science and Technology)

Session Title	Current status of precision medicine in colorectal cancer
Date & Time	6/20(Thu) 15:20-17:00	Place	Hanra A (3F)
1) Recent challenges for precision medicine in colorectal cancer Hideo Baba (Graduate School of Medical Sciences, Kumamoto University, Japan)
2) Application of clinical NGS in colorectal cancer: Asan Medical Center experience Jihun Kim (University of Ulsan College of Medicine)
3) Next-generation sequencing-based clinical sequencing: toward precision medicine in colorectal cancer Toshifumi Wakai (Niigata University Graduate School of Medical and Dental Sciences, Japan)
4) Precision medicine in colorectal cancer: Case review Jin Won Kim (Seoul National University Bundang Hospital)

Session Title	Advanced and innovative clinical research
Date & Time	6/20(Thu), 15:20-17:00	Place	Hanra B (3F)
1) Pragmatic clinical research and barriers: Precision medicine and Levine Cancer Institute experience Edward Kim (Atrium Health Levine Cancer Institute, USA)
2) Untold reality of medical device development Seung-June Oh (Seoul National University College of Medicine)
3) Innovations in clinical trials and future Jee Hyun Kim (Seoul National University College of Medicine)

Session Title	Recent precision medicine in gynecologic and breast cancer
Date & Time	6/20(Thu) 15:20-17:00	Place	Hanra C (3F)
1) Current status and future of genetic test Myong Cheol Lim (National Cancer Center)
2) Mismatch repair gene and gynecologic cancer Min Chul Choi (CHA University School of Medicine)
3) BRCAness and synthetic lethality Sung Jong Lee (The Catholic University of Korea College of Medicine)
4) Surveillance and risk-reducing strategies for breast cancer in women with BRCA mutations Hyung Seok Park (Yonsei University College of Medicine)
5) Precision medicine in gynecologic cancer Woong Ju (Ewha Womans University College of Medicine)

Session Title	Omics for innovative clinical cancer research
Date & Time	6/20(Thu) 15:20-17:00	Place	Shilla A (3F)
1) Studies on developing prediction models based on cancer transcroptome and clinical information Minho Lee (The Catholic University of Korea)
2) Enhancer remodeling and microRNA alterations are associated with acquired resistance to ALK inhibitors Mirang Kim (Korea Research Institute of Bioscience & Biotechnology)
3) Genomic research and clinical applications in breast cancer Wonshik Han (Seoul National University College of Medicine)
4) RNA biotype-associated molecular classification reveals novel driver transcripts in hepatitis B-related HCC Hyun Goo Woo (Ajou University School of Medicine)

Session Title	Exchange and cooperation of oncology between South and North Korea
Date & Time	6/20(Thu) 15:20-17:00	Place	Baekje B (4F)
1) The Korean peninsula: Our cause for a serious case over 70 years Sin Gon Kim (Korea University College of Medicine)
2) Study on the current state of cancer treatment in North Korea Hee Young Shin (Seoul National University College of Medicine)
3) Experience of healthcare project in North Korea Yoonsang Lee (Nanum International)

Session Title	Recent updates in the development of immune-therapy for cancer treatment
Date & Time	6/20(Thu) 13:20-15:00	Place	Goguryeo (5F)
1) Molecular differentiation and novel combination therapies Wallace Mondesire (MSD, USA)
2) Microsatellite instability and hypermutation of cancer genomes Tae-Min Kim (The Catholic University of Korea College of Medicine)
3) Advances in systemic therapy for renal cell carcinoma: immune checkpoint blockade in combination with tyrosine kinase inhibitors Victoria Robinson (MSD, USA)

Session Title	GC academy- Special talk for antiangiogenic agents in mGC treatment
Date & Time	6/20(Thu) 15:20-17:00	Place	Goguryeo (5F)
Introduction	Hearing from Experts : Deep dive into treatment HER2+ in mGC, Real World Evidence in mGC treatment and treatment of mGC in the future
1) How do we go through the HER+ GC? Jin-Soo Kim (Seoul National University Boramae Medical Center)
2) From the start to future in antiangiogenic agent in GC Sun Young Rha (Yonsei University College of Medicine)
3) Real world evidence of ramucirumab in gastric cancer Keun-Wook Lee (Seoul National University College of Medicine)

Session Title	Individualized treatment decision for optimal sequence in mCRC, with aflibercept
Date & Time	6/20(Thu) 12:20-13:20	Place	Hanra A (3F)
Julien Taieb (Georges Pompidou European Hospital, Sorbonne Paris-Cite, Universite Paris-Descartes, France)

Session Title	Liposomal irinotecan, new hope for the treatment of metastatic pancreatic cancer
Date & Time	6/20(Thu) 12:20-13:20	Place	Hanra B (3F)
Changhoon Yoo (University of Ulsan College of Medicine)

Session Title	Cutting-edge front-line treatment for advanced non-small cell lung cancer
Date & Time	6/20(Thu) 12:20-13:20	Place	Hanra C (3F)
Tae Min Kim (Seoul National University College of Medicine)

Session Title	Navigating the treatment journey for patients with oncogene-driven NSCLC
Date & Time	6/20(Thu) 12:20-13:20	Place	Shilla A (3F)
Takashi Seto (Kyushu Cancer Center, Japan)

Session Title	Precision medicine in head and neck and lung cancer
Date & Time	6/20(Thu), 15:20-17:00	Place	Baekje C (4F)
1) HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer Chul-Ho Kim (Ajou University School of Medicine)
2) Targeted disruption of PI3K/Akt/mTOR signaling pathway leads to destruction of oral squamous cell carcinoma (OSCC) cells Sadhna Aggarwal (All India Institute of Medical Sciences, India)
3) Association of p53 codon 72 arg/pro polymorphism with lung cancer risk in the South Asian population: A meta-analysis Mohammad Safiqul Islam (Noakhali Science and Technology University, Bangladesh)
4) Outcome of induction chemotherapy followed by surgery in T4b buccal cancer patients Prasad Kasbekar (Gujarat Cancer and Research Institute, India)
5) EGFR mutations in non-small-cell lung cancers: A single institute experience Comparison of PANAMutyper™ and targeted Next-Generation Sequencing (NGS)-A significant discordance Jeonghyo Lee (Seoul National University Bundang Hospital)
6) Elective neck dissection in salvage surgery for laryngeal squamous cell carcinoma: A single institutional experience Pavan Karella (Gujarat Cancer and Research Institute, India)
7) Can we predict lymph node metastasis in early oral cancer through measuring tumor thickness by intraoral ultrasound? Jeewan Ram Vishnoi (All India Institue of Medical Sciences, India)

Session Title	Epigenetics, DNA, RNA in cancer
Date & Time	6/20(Thu), 17:00-18:00	Place	Hanra B (3F)
1) PRISM: Methylation pattern-based, reference-free inference of subclonal makeup Dohoon Lee (Seoul National University)
2) Cell adhesion to mesenchymal stem cells mediates resistance to oxidative phosphorylation inhibition in acute myeloid leukemia Haeun Yang (Juntendo University Graduate School of Medicine, Japan)
3) Interplay between slow-cycling, chemoresistant cancer cells and fibroblasts creates a proinflammatory niche for tumor progression Jaebeom Cho (Seoul National University)
4) Treatment of megakaryoblastic leukemia Dami cells with phorbol ester regulates the long non-coding RNA signature Ravi Kumar Gutti (University of Hyderabad, India)
5) Assessment of knowledge, attitude,and practices and associated factors towards palliative care among health care providers to the pediatric oncology patients in southern Philippines Jayson Pasaol (National Cancer Center- Graduate School of Cancer Science and Policy)

Session Title	Omics and digital applications in cancer
Date & Time	6/20(Thu), 17:00-18:00	Place	Hanra A (3F)
1) Deep learning based tumor microenvironment predicts survival in gastric adenocarcinoma You Jeong Heo (Samsung Medical Center, Sungkyunkwan University School of Medicine)
2) The comparative analysis of tumor-specific microbiome and the oncological study of the identified microbe in exosome of pancreatic tumor tissue Eunsung Jun (Asan Medical Center)
3) Cancer panel assay for precision oncology clinic: Results from a one-year study Dohee Kwon (Samsung Medical Center)
4) Short- and long-term mortality prediction in critically ill cancer patients admitted to intensive care unit with machine learning Han Sang Kim (Yonsei Cancer Center)
5) Identification of novel fusion partner and new therapeutic target by targeted RNA sequencing in solid tumors Sungbin An (SAIHST, Sungkyunkwan University School)
6) Assessing concordance with Watson for Oncology cognitive computing system for colorectal cancer treatment In Hee Lee (Catholic University of Daegu, School of Medicine)

Session Title	Issues in women cancers
Date & Time	6/20(Thu), 17:00-18:00	Place	Hanra C (3F)
1) Survival outcome for breast cancer patients with brain metastasis: A multicenter retrospective study in Korea (KROG 16-12) Jae Sik Kim (Seoul National University College of Medicine)
2) Local disease control followed by anti-HER2 therapy improves overall survival of HER2-positive metastatic breast cancer patients Seul-Gi Kim (Yonsei Cancer Center, Yonsei University College of Medicine)
3) SUV max of 18F FDG-PET/CT: A predictive factor associated with pathologic complete response in luminal HER2-negative breast cancer patients receiving neoadjuvant chemotherapy Soo Jung Lee (Kyungpook National University Chilgok Hospital)
4) The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian insufficiency in patient with malignant ovarian germ cell tumors (KGOG-OV1813) Min Chul Choi (CHA Bundang Medical Center, CHA University)
5) Prognostic value of tumor heterogeneity evaluated by 18F[FDG] PET/CT in invasive squamous cell carcinoma of uterine cervix Maria Lee (Seoul National University College of Medicine)
6) Clinical outcome of stage IVB cervical cancer treated with chemoradiotherapy with or without bevacizumab Sang Hee Youn (Research Institute and Hospital, National Cancer Center)

Session Title	Implements from novel observations
Date & Time	6/20(Thu), 17:00-18:00	Place	Baekje B (4F)
1) Bacillus calmette-guerin cell wall cytoskeleton with encapsulated liposome enhances antitumor effect in bladder cancer through inhibition of mTOR activity and induction of ER stress Young Mi Whang (Chung-Ang University College of Medicine)
2) Antitumor effect of a WEE1 inhibitor and potentiation of PARP inhibitor sensitivity by modulation of DNA damage response Dong-Hyeon Ha (Seoul National University)
3) Identification of invasion-deterministic transcription factors in glioblastoma using integrative transcriptome analysis Junseong Park (Yonsei University College of Medicine)
4) Exosomal microRNA-199b-5p as a potential circulating biomarker to predict response of preoperative chemoradiotherapy for locally advanced rectal cancer Hee Jeong Cho (Kyungpook National University Chilgok Hospital, Kyungpook National University School of Medicine)
5) Association between kidney function, proteinuria and the risk of kidney cancer: A nationwide cohort study involving 10 million participants Jinsung Park (Eulji University Hospital, Eulji University School of Medicine)
6) The local recurrence without metastasis had significantly worse prognostic survivals than the metastasis without local recurrence after curative nephrectomy in non-metastatic renal cell carcinoma Sung Han Kim (Urological Cancer Center, National Cancer Center)

Date & Time	6/20(Thu), 09:00-17:00	Place	Baekdu (5F)

Date & Time	6/21(Fri) 10:20-10:50	Place	Hanra (3F)
The complex path to cancer precision medicine Yeul Hong Kim (Korea University College of Medicine)

Date & Time	6/21(Fri) 10:50-11:40	Place	Hanra (3F)
Tumor and host factors regulating anti-tumor immunity and immunotherapy efficacy Thomas Gajewski (University of Chicago, USA)

Session Title	Overseas Young Investigator Symposium
Date & Time	6/21(Fri) 09:00-10:10	Place	Hanra C (3F)
1) Mechanisms underlying synergy of Topo I and mTOR co-inhibition in Malignant Peripheral Nerve Sheath Tumors Dong Hyuk Ki (Harvard Medical School/Dana-Farber Cancer Institute, USA)
2) Tumor interferon signaling: Implications for cancer immunotherapy Daniel Sanghoon Shin (David Geffen School of Medicine at UCLA, USA)
3) Advancing the promise of chemoimmunotherapy in solid tumors Youngwook Won (University of Arizona College of Medicine, USA)

Session Title	Basic immunology: (Treatment-resistant) Tumor microenvironment
Date & Time	6/21(Fri) 13:40-15:20	Place	Hanra A (3F)
1) Progressive impairment of NK cell cytotoxic degranulation is associated with TGF-β1 deregulation and disease progression in pancreatic cancer Hun Sik Kim (University of Ulsan College of Medicine)
2) Targeting the tumor associated macrophages (TAMs) in pre-metastatic niche Seung Hyeok Seok (Seoul National University College of Medicine)
3) NANOG drives stem-like state and resistance to multi-modality of immune-edited tumor cells Tae Woo Kim (Korea University College of Medicine)

Session Title	Immune targeted biomarkers in therapeutic decision making
Date & Time	6/21(Fri) 13:40-15:20	Place	Hanra B (3F)
1) Comparison of PD-L1 assays in urothelial carcinoma Kyu Sang Lee (Seoul National University College of Medicine)
2) Pathologic interpretation of immune biomarkers in gastric cancer Hyunki Kim (Yonsei University College of Medicine)
3) Molecular basis of immune response heterogeneity in colorectal cancers: Potential biomarkers Jung Ho Kim (Seoul National University Hospital)
4) Genomic features associated with transcriptome-based cancer immunoprofiling Tae-Min Kim (The Catholic University of Korea College of Medicine)

Session Title	National OncoVenture Symposium Promising anti-cancer drug pipeline in pre-clinical and clinical stages in Korea
Date & Time	6/21(Fri) 13:40-15:20	Place	Hanra C (3F)
1) Campaign NOV1801; Anti-4-1BB antibody, an immune checkpoint regulator Joong Won Lee (Eutilex)
2) Fast follower-Best in class strategy, Pan-TRK inhibitor (NOV1601) Sang-Yoon Lee (HANDOK)
3) Development of NOV140101(IDX-1197); A novel, selective, and highly potent PARP inhibitor SungKu Choi (Ildong Pharmaceutical)

Session Title	Tumor microenvironment of solid cancer
Date & Time	6/21(Fri) 13:40-15:20	Place	Shilla A (3F)
1) Single-cell RNA sequencing reveals tumor microenvironment and intratumoral heterogeneity Semin Lee (Ulsan National Institute of Science and Technology)
2) Targeting CAF-TAM interaction to inhibit cancer metastasis Darren Reece Williams (Gwangju Institute of Science and Technology)
3) Cancer-restraining cancer-associated fibroblasts and their roles in tumor progression and immunity Atsushi Enomoto (Nagoya University, Japan)
4) Tumor microenvironment remodeling by intratumoral oncolytic virus to enhance immune checkpoint blockade Chan Kim (CHA University School of Medicine)

Session Title	Underlying mechanisms of novel cellular therapies
Date & Time	6/21(Fri) 15:40-17:20	Place	Hanra A (3F)
1) Development of tumor infiltrating therapy for melanoma and other solid tumors Chantale Bernatchez (MD Anderson Cancer Center, USA)
2) TLR9 agonists in combination with anti-CTLA-4 checkpoint inhibitors for the treatment of patients with anti-PD-1 refractory melanoma Cara Haymaker (MD Anderson Cancer Center, USA)
3) Immuno-genomic approach to enrich the responder and overcome the resistance of immune checkpoint inhibitor Chan-Young Ock (Seoul National University Hospital)

Session Title	Microbiology and microbiome in cancer
Date & Time	6/21(Fri) 15:40-17:20	Place	Hanra B (3F)
1) Neutropenic fever in cancer patients Dong-Gun Lee (The Catholic University of Korea College of Medicine)
2) Understanding and analysis of the human microbiome in cancer biology Ju Sun Song (Green Cross Genome)
3) Microbiome meets cancer and immunology Hansoo Park (Gwangju Institute of Science and Technology)

Session Title	Current practice and dilemma in oligometastatic disease of lung cancer
Date & Time	6/21(Fri) 15:40-17:20	Place	Hanra C (3F)
1) Pathologic and molecular characterization of oligometastatic disease Dong Hoon Shin (Pusan National University School of Medicine)
2) Surgical treatment of oligometastatic disease Hyun Koo Kim (Korea University College of Medicine)
3) Radiotherapy for oligometastatic disease of lung cancer Yang-Gun Suh (National Cancer Center)
4) Systemic therapy update in oligometastatic disease Sook Hee Hong (The Catholic University of Korea College of Medicine)

Session Title	암관련학회협의체 심포지엄
Date & Time	6/21(Fri) 15:40-17:20	Place	Shilla A (3F)
1) Behaviors and attitudes toward the use of complementary and alternative medicine among Korean cancer patients Jung Hye Kwon (Hallym University College of Medicine)
2) Challenging issues in off label use for rare cancers Dae Ho Lee (University of Ulsan College of Medicine)
3) Cancer survivorship Ji Soo Park (Yonsei University College of Medicine)
4) Panel Discussion

Session Title	How to generate and utilize RWE (real-world evidence) in oncology
Date & Time	6/21(Fri) 13:40-15:20	Place	Goguryeo (5F)
Introduction	Real-world evidence (RWE) is becoming more and more important in this precision oncology era, where RWE shows how drugs perform in real patient groups outside of clinical trials and impacts clinical decision-making by giving a better sense of how treatments could affect patients' health. In this Master Class, the value of RWE will be reviewed in the perspectives of physician, regulatory process and pharmaceutical industry and future direction of RWE will be discussed.
1) The value of RWE to oncologists Dae Ho Lee (University of Ulsan College of Medicine)
2) Application of real-world evidence in drug approval and post-marketing study in regulatory process Ju-Young Shin (Sungkyunkwan University)
3) What RWE means to pharmaceutical company Camille Perret (Roche, Switzerland)
4) Q&A and panel discussion

Session Title	'Standard of Care' to 'Standard of Survival': Unfolding the quantum leap in mNSCLC
Date & Time	6/21(Fri) 11:50-12:50	Place	Hanra A (3F)
Ji Hyun Park (Konkuk University School of Medicine)

Session Title	The evolving power of immunotherapy: Atezolizumab in advanced lung cancer
Date & Time	6/21(Fri) 11:50-12:50	Place	Hanra C (3F)
Ji-Youn Han (National Cancer Center)

Session Title	An optimal post-progression treatment option to improve outcomes in advanced gastric cancer: Clinical experiences with ramucirumab
Date & Time	6/21(Fri) 11:50-12:50	Place	Shilla A (3F)
Keun-Wook Lee (Seoul National University College of Medicine)

Date & Time	6/21(Fri), 09:00-10:00	Place	Hanra A (3F)
1) 4-1BB delineates distinct activation status of exhausted tumor-infiltrating CD8+ T cells in hepatocellular carcinoma Hyung-Don Kim (Korea Advanced Institute of Science and Technology)
2) KEAP1/NFE2L2/CUL3 mutations in therapeutic resistance and prognosis of non-small cell lung cancers Youngtae Jeong (DGIST / Stanford University School of Medicine)
3) Identification of galectin-3 binding protein (Gal-3BP) as a novel therapeutic target for PDAC and the development of Gal-3BP antibody that suppresses metastasis via EGFR-Myc-EMT inhibition Suhwan Chang (University of Ulsan, Asan Medical Center)

Session Title	Biomarkers and models in cancer immunotherapy
Date & Time	6/21(Fri), 09:00-10:00	Place	Baekje C (4F)
1) Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer Sun Min Lim (CHA Bundang Medical Center)
2) Immunologic and prognostic characterization of early triple-negative breast cancer according to the presence of PD-L1 positive immune cells assessed by SP-142 Sung Gwe Ahn (Gangnam Severance Hospital, Yonsie University College of Medicine)
3) Tumor mutational burden as a potential predictive biomarker of response to PD-1/PD-L1 blockade in non-small cell lung cancer Hyojin Kim (Seoul National University Bundang Hospital)
4) The effects of tumor-associated macrophages on colon cancer cell migration in a 3-dimensional microfluidic chip Yeo Song Lee (Sungkyunkwan University School of Medicine / Institute for Future Medicine Samsung Medical Center)

Session Title	Translational research in women cancers
Date & Time	6/21(Fri), 13:40-15:00	Place	Baekje B (4F)
1) Long noncoding RNA and glucose metabolism in breast cancer Je-Hyun Yoon (Medical University of South Carolina, USA)
2) Prospectively patient-reported outcome measures in breast cancer patients treated for late radiation-induced tissue toxicity byhyperbaric oxygen therapy, 6 months follow-up David Teguh (Amsterdam University Medical Center, Netherlands)
3) TFCP2 mediates EGF/TGF-α expression to active EGFR signaling and promotes progression of TNBC Yi Zhao (Hanyang University)
4) Pattern of genetic variation in ovarian cancer according to clinical variables Jaehee Mun (Seoul National University College of Medicine)

Session Title	Special populations in cancer prevention
Date & Time	6/21(Fri), 13:40-15:00	Place	Baekje C (4F)
1) Higher risk of pancreatic cancer in middle-aged men with diabetes mellitus: A 10-year nationwide population-based cohort study Dong-Hoe Koo (Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
2) Prevalence and associated factors of goiter among school-aged children: Results from school-based screening program in an urban of Vietnam Minh Tu Nguyen (Hue University of Medicine and Pharmacy, Vietnam)
3) Incidence and survival of Korean adolescents and young adults diagnosed with cancer in 1999-2016 Meerim Park (Center for Pediatric Cancer, National Cancer Center)
4) Awareness and assessment of oral cancer and precancerous oral lesions among Paniya tribes of Wayanad, India: A cross sectional study Shanavas Palliyal (DM Wayanad Institute of Medical Sciences, India)
5) Determinants of intentions to quit smoking among daily smokers in Vietnam: results from Global Adult Tobacco Survey (GATS) 2010 and 2015 Binh Thang Tran (National Cancer Center Graduate School of Cancer Science and Policy)

Session Title	Translational research in GI cancers
Date & Time	6/21(Fri), 15:40-17:00	Place	Baekje B (4F)
1) Modeling signet ring cell gastric cancer by using mouse models and organoids Masahiro Hata (The University of Tokyo, Japan)
2) Comprehensive genomic analysis of clonal evolution during metastasis in gallbladder adenocarcinoma (GBAC) Ji-Won Kim (Seoul National University Bundang Hospital)
3) The effectiveness and feasibility of extended-field radiotherapy using modern radiotherapy techniques for squamous cell carcinoma of the esophagus without lymph node metastasis Eun Sang Oh (National Cancer Center Graduate School of Cancer Science and Policy)
4) The risk of pathogenic germline variants of patients with double primary cancer at stomach and colon Yoon Young Choi (Yonsei University Health System)
5) Role of hormonal therapy in advanced gall bladder carcinoma patients: An Indian institutional experience Aseem Rai Bhatnagar (Shalby Hospital, India)

Session Title	New methods in tumor biology
Date & Time	6/21(Fri), 15:40-17:00	Place	Baekje C (4F)
1) The paradoxical roles of ZEB1 in thyroid cancers: A putative diagnostic and therapeutic target Minjun Kim (Seoul National University College of Medicine)
2) miR-15b-5p and miR-222-3p: Potential oncomiRs in air pollution-related lung cancer Nurul-Syakima Ab Mutalib (National University of Malaysia, Malaysia)
3) The role of XRCC4 in human colon cancer stem cells and radiosensitivity Sei Sai (National Institutes for Quantum and Radiological Science and Technology, Japan)
4) Epigenetic activation of a tumor suppressor gene in human ovarian carcinomas Chang Sung (Texas A&M University-Kingsville, USA)
5) Predominant DICER1 mutations in pediatric follicular thyroid carcinomas Young Ah Lee (Seoul National University Children's Hospital)

Session Title	Translational research in head and neck and lung cancer
Date & Time	6/21(Fri), 09:00-10:00	Place	Baekje B (4F)
1) BRAFV600E mutation enhances tumorigenic effects of estrogen on human thyroid cells by regulating expression of estrogen receptors Minjun Kim (Seoul National University College of Medicine)
2) Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment and response to immune checkpoint blockade Min Hwan Kim (Yonsei Cancer Center)
3) Prediction of recurrence-free survival of non-small cell lung cancer using time-binned deep neural network Ho Jung An (St. Vincent's Hospital, The Catholic University of Korea)
4) The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study Yoon Ho Ko (Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
5) Comparison of lung cancer screening trials from East Asia; South Korea, Japan, and Taiwan Sang Won Shin (Korea University College of Medicine)

Date & Time	6/21(Fri), 09:00-17:00	Place	Baekdu (5F)